Life Science
Cancer Diagnostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
Cancer Diagnostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
Couldn't load pickup availability
Cancer Diagnostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global cancer diagnostics market is expected to grow at a CAGR of around 8.3% during 2023-2030. This report on global cancer diagnostics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global cancer diagnostics market by segmenting the market based on product, technology, type, application, end user, and region. Also, detailed profiles of companies operating in the cancer diagnostics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Rising Prevalence of Cancer
• The Increase in Adoption of Latest Technologies
Market Challenges
• High Cost
• Inadequate Reimbursement Policies
Historical & Forecast Period
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Product
• Consumables
Antibodies
Kits and Reagents
Probes
Others
• Instruments
Pathology-based Instruments
Imaging Instruments
Biopsy Instruments
Market by Technology
• IVD Testing
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Microarrays
Flow Cytometry
Immunoassays
Others
• Imaging
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Mammography
Ultrasound
• Biopsy Technique
Market by Type
• Biopsy
• Endoscopy
• Imaging
• Genetic Tests
• Laboratory Tests
• Others
Market by Application
• Breast Cancer
• Lung Cancer
• Cervical Cancer
• Kidney Cancer
• Liver Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Other Applications
Market by End User
• Hospitals and Clinics
• Diagnostic Laboratories
• Others
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa